ImmunologybioRxiv
BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine
D. J. Perera, P. Domenech, G. G. Babuadze…·M. Ndao
BCG enhances anti-SARS-CoV-2 immunity and protection afforded by a novel adenovirus-vectored vaccine.
DOI 10.1016/j.isci.2023.107612